Tofacitinib citrate CAS: 540737-29-9
| Product Parameters | |
|---|---|
| Catalog No. | BA5U9M |
| CAS.RN | 540737-29-9 |
| Molecular Formula | C22H28N6O8 |
| Molecular Weight | 504.49 g/mol |
| Purity | NLT 98% |
Product Overview
Tofacitinib citrate is a highly selective JAK inhibitor widely used in the research and development of treatments for autoimmune diseases, particularly demonstrating good clinical efficacy in indications such as rheumatoid arthritis. As an active pharmaceutical ingredient (API), this product is suitable for all stages of drug development, process development, pilot-scale amplification, and commercial production. It possesses stable chemical properties and excellent biological activity, meeting the stringent requirements of pharmaceutical companies for high-quality APIs.
Applications
- Rheumatoid arthritis drug development
- Treatment development for autoimmune diseases
- JAK pathway-related target research
- Synthesis of innovative drug intermediates
- Process optimization and route validation for pharmaceutical companies
Quality & Supply Capability
English Name: Tofacitinib citrate Properties: This product is a white to off-white crystalline powder with good thermal and chemical stability. Its molecular structure contains a piperazine ring and phenyl substituents, classifying it as a small-molecule organic compound. It is readily soluble in polar solvents and suitable for various synthetic routes. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Document Support: COA, MSDS, HPLC, NMR, etc. We provide comprehensive services from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized mass production. We can flexibly adjust supply solutions according to customers' specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to assist customers in completing the entire process from laboratory R&D to industrial scale-up, ensuring the feasibility and stability of the process route and facilitating the smooth transformation and implementation of projects.
Why Choose Bioncan
Focused on supplying JAK inhibitor APIs, possessing a rich product line and technological expertise. Full-scale supply capabilities covering all stages from laboratory to commercial production. Provides complete quality control documentation, including key reports such as COA, MSDS, HPLC, and NMR. Supports customized needs, adjusting purity, impurity limits, and packaging according to customer requirements. Provides comprehensive process optimization and scale-up technical support to ensure efficient R&D and production for our clients.
Intermediates of Tofacitinib citrate
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA5U9M | Tofacitinib citrate API | 540737-29-9 |
| BK3X1C | (3S,4S)-Tofacitinib | 1092578-47-6 |
| BK4K39 | (R)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione | 181140-34-1 |
| BK1Y86 | 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, (3R,4S)-rel- | 1431697-80-1 |
| BK8SN5 | (3S,4R)-Tofacitinib | 1092578-48-7 |
| BK24NH | (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine (rel) | 477600-69-4 |
| BK5SH8 | (3R,4S)-Tofacitinib | 1092578-46-5 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 540737-29-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.